LeonaBio annual total assets
2019
2020
2021
2022
2023
2024
2025
LeonaBio Total Assets Growth & History (LONA)
LeonaBio's total assets was $92.2M for fiscal 2025.
View full LeonaBio company overviewLeonaBio annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $92.2M | $33.4M | +56.78% |
| 2024 | 2024-12-31 | $58.8M | −$101.5M | −63.32% |
| 2023 | 2023-12-31 | $160.2M | −$97.9M | −37.93% |
| 2022 | 2022-12-31 | $258.2M | −$73.9M | −22.24% |
| 2021 | 2021-12-31 | $332.0M | $52.4M | +18.76% |
| 2020 | 2020-12-31 | $279.6M | $277.4M | +12671.27% |
| 2019 | 2019-12-31 | $2.2M | — | — |
LeonaBio quarterly total assets
Q4.19
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $56.9M | $21.3M | +60.06% |
| Q1 2026 | 2026-03-31 | $71.6M | $28.1M | +64.53% |
| Q4 2025 | 2025-12-31 | $92.2M | $33.4M | +56.78% |
| Q3 2025 | 2025-09-30 | $30.0M | −$56.2M | −65.18% |
| Q2 2025 | 2025-06-30 | $35.5M | −$75.7M | −68.05% |
| Q1 2025 | 2025-03-31 | $43.5M | −$89.9M | −67.40% |
| Q4 2024 | 2024-12-31 | $58.8M | −$101.5M | −63.32% |
| Q3 2024 | 2024-09-30 | $86.2M | −$98.5M | −53.30% |
| Q2 2024 | 2024-06-30 | $111.3M | −$96.8M | −46.53% |
| Q1 2024 | 2024-03-31 | $133.5M | −$99.3M | −42.67% |
| Q4 2023 | 2023-12-31 | $160.2M | −$97.9M | −37.93% |
| Q3 2023 | 2023-09-30 | $184.7M | −$89.5M | −32.64% |
| Q2 2023 | 2023-06-30 | $208.0M | −$84.0M | −28.75% |
| Q1 2023 | 2023-03-31 | $232.8M | −$80.2M | −25.63% |
| Q4 2022 | 2022-12-31 | $258.2M | −$73.9M | −22.24% |
| Q3 2022 | 2022-09-30 | $274.2M | −$73.1M | −21.06% |
| Q2 2022 | 2022-06-30 | $292.0M | −$68.1M | −18.91% |
| Q1 2022 | 2022-03-31 | $313.0M | −$56.4M | −15.27% |
| Q4 2021 | 2021-12-31 | $332.0M | $52.4M | +18.76% |
| Q3 2021 | 2021-09-30 | $347.3M | $79.4M | +29.63% |
| Q2 2021 | 2021-06-30 | $360.1M | — | — |
| Q1 2021 | 2021-03-31 | $369.4M | — | — |
| Q4 2020 | 2020-12-31 | $279.6M | $277.4M | +12671.27% |
| Q3 2020 | 2020-09-30 | $267.9M | — | — |
| Q4 2019 | 2019-12-31 | $2.2M | — | — |
LeonaBio total assets trends
Over the last five fiscal years, LeonaBio's total assets decreased from $279.6M to $92.2M, a change of −$187.4M. The latest reported quarter, Q2 2026, shows $56.9M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review LeonaBio source filings ↗